Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. bras. farmacogn ; 24(5): 538-544, Sep-Oct/2014. tab, graf
Article in English | LILACS | ID: lil-730556

ABSTRACT

Gastric ulcers are a significant medical problem and the development of complications lead to significant mortality rates worldwide. In Brazil, Carthamus tinctorius L., Asteraceae, seeds essential oil, the safflower oil, is currently used as a thermogenic compound and as treatment for problems related to the cardiovascular system. In this study, by Raman spectroscopy, it was shown that oleic and linoleic acids are the compounds present in higher concentrations in the safflower oil. We demonstrated that safflower oil (750 mg/kg, p.o.) decrease the ulcerogenic lesions in mice after the administration of hydrochloric acid-ethanol. The gastric ulcers induced by non-steroidal anti-inflammatory drug (NSAID) in mice treated with cholinomimetics were treated with four different doses of safflower oil, of which, the dose of 187.5 mg/kg (p.o.) showed significant antiulcerogenic properties (**p < 0.01). Moreover, the safflower oil at doses of 187.5 mg/kg (i.d.) increased the pH levels, gastric volume (**p < 0.01) and gastric mucus production (***p < 0.001), and decreased the total gastric acid secretion (***p < 0.001). The acute toxicity tests showed that safflower oil (5.000 mg/kg, p.o.) had no effect on mortality or any other physiological parameter. Ecotoxicological tests performed using Daphnia similis showed an EC50 at 223.17 mg/l, and therefore safflower oil can be considered “non-toxic” based on the directive 93/67/EEC on risk assessment for new notified substances by European legislation. These results indicate that the antiulcer activity of Safflower oil may be due to cytoprotective effects, which serve as support for new scientific studies related to this pathology.

2.
Ciênc. cult. (Säo Paulo) ; 49(5/6): 402-50, Sept.-Dec. 1997.
Article in English | LILACS | ID: lil-214103

ABSTRACT

This paper presents a reflection based on the experience generated by fifteen years of studies on pharmacology and chemistry of medicinal plants, in a underdeveloped country, Brazil. Although the diversity of the Brazilian flora presents a remarkable opportunity towards the development of new medicinal products, there are only small natural products research groups. Strategies for pharmacological and chemical studies of medicinal plants investigated during this time, major difficulties and ways to bypass them are discussed. The ethnopharmacological approach adopted as a general method by our research team has given good results. Details of our experience in the way to develop new plant durgs are reviewed and updated.


Subject(s)
Drugs, Investigational , Plant Extracts/therapeutic use , Plants, Medicinal , Brazil , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Research
SELECTION OF CITATIONS
SEARCH DETAIL